7th Jan 2015 07:00
7 January 2015
Collagen Solutions Plc
(the "Company" or the "Group")
CEO to present at the OneMedForum
Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announces that its CEO, Stewart White, will be presenting at OneMedForum on 12 January 2015 in San Francisco.
Formerly known as the H&Q (Hambrecht & Quist) Conference, OneMedForum is an industry summit for healthcare financiers, industry executives and growth companies from around the world. The objective of OneMedForum is to assemble the most promising companies and technologies in health and medicine and help them to successfully connect with the industry's leading investors and healthcare executives.
Dr Stewart White, Chief Executive Officer of Collagen Solutions plc said: "We were pleased to be invited to attend and present at this very prestigious conference. The Company has made significant progress in the last twelve months demonstrating both its global reach and diversified business model. This is an ideal forum to present these achievements to a global audience of companies and investors."
Presentations and interviews with executives will be available on a webcast and thereafter archived. Details of how to access the webcast and archive will be made available ahead of the meeting.
Enquiries:
Collagen Solutions Plc |
|
David Evans, Chairman | Tel: 07740 084 452 |
Stewart White, CEO | Tel: 0141 558 2008 |
|
|
Zeus Capital (Nominated Adviser and Broker) |
|
Ross Andrews / John Depasquale | Tel: 0161 831 1512 |
Alex Davies | Tel: 020 7533 7727 |
|
|
Panmure Gordon & Co (Joint Broker) Robert Naylor (Corporate Finance) | Tel: 020 7886 2714Tel: 020 7886 2905 |
Maisie Atkinson (Corporate Broking) |
|
|
|
Walbrook PR Ltd | Tel: 020 7933 8780 or [email protected] |
Mike Wort | Mob: 07900 608 002 |
Anna Dunphy | Mob: 07876 741 001 |
Notes to Editors:
Collagen Solutions operates from three facilities in the UK, New Zealand and the USA. Manufacturing is carried out at two state of the art facilities in the UK and New Zealand where animal derived collagen is processed into medical grade collagen formulations and components.
Collagen Solutions is committed to providing the highest quality, medical grade biomaterials to support medical devices and other products for regenerative medicine across a wide range of applications and clinical indications. In addition it provides materials for the manufacture of in-vitro diagnostics.
Related Shares:
COS.L